ReviewNature reviews. Neurology2021
Can we learn lessons from the FDA's approval of aducanumab?
Kathy Y Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this paperpooled ittrialcites it
ReviewNature reviews. Neurology2021
Kathy Y Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.